Effect of carbocisteine on nasal discharge and post nasal discharge in patients with acute rhinosinusitis after antibiotic treatment
Not Applicable
- Conditions
- Acute rhinosinusitis
- Registration Number
- JPRN-UMIN000007214
- Lead Sponsor
- Wakayama-Okayama Otolaryngology Pharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who cannot tolerate carbocisteine 2.Patients who received airway disease drugs (mucolytic agents) within 10 days to the start of this study 3.Patients who were scheduled to later receive airway disease drugs at the start of this study 4.Patients participating in other studies at the start of this study 5.Patients with history of severe hepatic diseases, renal diseases, cardiovascular diseases, or other cormobidities 6.Patients with a complication of malignant tumors 7.Women who are not pregnant or lactating, and not expecting future pregnancy 8.Patients who are judged inappropriate by physicians in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method